sorafenib has been researched along with carvacrol in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (carvacrol) | Trials (carvacrol) | Recent Studies (post-2010) (carvacrol) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,231 | 19 | 958 |
| Protein | Taxonomy | sorafenib (IC50) | carvacrol (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 4 | |
| Secreted chorismate mutase | Mycobacterium tuberculosis H37Rv | 1.06 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abo El-Magd, NF; El Gayar, AM; Yousef, EH | 1 |
1 other study(ies) available for sorafenib and carvacrol
| Article | Year |
|---|---|
Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Line, Tumor; Cell Proliferation; Liver Neoplasms; Rats; Sorafenib; Thioacetamide; TRPM Cation Channels | 2023 |